Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 08, 2018 08:19 ET | Source: Biomerica, Inc.

Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)

- DGT Designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms - DGT can be used alongside current IBS drug treatments to potentially improve...
November 07, 2017 08:19 ET | Source: Biomerica, Inc.

Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

IRVINE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA) today announced that it has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea. Celtis...
October 17, 2017 08:19 ET | Source: Biomerica, Inc.

Biomerica Reports 1st Quarter Fiscal 2018 Financials

IRVINE, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,444,483 for the three months ending August 31, 2017, compared to $1,410,110 for the...
September 12, 2017 08:19 ET | Source: Biomerica, Inc.

Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test

IRVINE, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA) today announced that the Company has commenced clinical studies to evaluate the performance of its new and proprietary...
August 30, 2017 08:19 ET | Source: Biomerica, Inc.

Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year

IRVINE, Calif., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA), a global provider of advanced diagnostic products, today reported net sales for the fiscal year 2017 were $5,791,670...
August 16, 2017 08:19 ET | Source: Biomerica, Inc.

Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company

IRVINE, Calif. , Aug. 16, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced today a distribution agreement to supply one of its point of care products to a multinational...
May 23, 2017 07:29 ET | Source: Biomerica

Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

IRVINE, CA--(Marketwired - May 23, 2017) - Biomerica Inc. (NASDAQ: BMRA) today announced it will present at the 18th Annual B. Riley institutional investor conference being held May 24-25, 2017 in...
April 17, 2017 08:19 ET | Source: Biomerica

Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months

IRVINE, CA--(Marketwired - April 17, 2017) - Biomerica, Inc. (NASDAQ: BMRA) today reported net sales of $4,342,247 for the nine months ending February 28, 2017, compared to $3,813,683 for the period...
March 09, 2017 08:19 ET | Source: Biomerica

Biomerica to present at the 29th Annual ROTH conference on March 13, 2017

IRVINE, CA--(Marketwired - March 09, 2017) - Biomerica Inc. (NASDAQ: BMRA) today announced it will present at the 29th Annual ROTH Conference being held March 12-15, 2017 in Dana Point, CA.Zackary...
January 18, 2017 08:19 ET | Source: Biomerica

Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter

IRVINE, CA--(Marketwired - January 18, 2017) - Biomerica, Inc. (NASDAQ: BMRA) today reported net sales of $1,432,206 for the three months ended November 30, 2016, compared to $1,165,080 for the same...